首页 | 本学科首页   官方微博 | 高级检索  
     

错配修复基因 hMLH1 和hMSH2 在胃癌组织中的表达及意义
引用本文:范凯,马坚妹,刘敏,吕申,许国旺. 错配修复基因 hMLH1 和hMSH2 在胃癌组织中的表达及意义[J]. 中国老年学杂志, 2005, 25(2): 165-167
作者姓名:范凯  马坚妹  刘敏  吕申  许国旺
作者单位:1. 大连医科大学附属第二医院实验中心
2. 大连医科大学解剖教研室,辽宁,大连,116027
3. 大连医科大学附属第二医院实验中心;中国科学院大连化学物理研究所
4. 中国科学院大连化学物理研究所
基金项目:中科院知识创新工程领域前沿基金课题(No.DICPkaaaabc)
摘    要:目的探讨错配修复基因hMLH1 和hMSH2 在胃癌发生中的作用.方法采用免疫组化SP法,检测散发性胃癌、癌旁黏膜和胃炎黏膜组织中hMLH1 和 hMSH2基因的表达情况.结果 hMSH2在胃癌组织中的阳性表达率(67.1%)显著高于癌旁黏膜(41.4%)和胃炎黏膜组织(41.2%)(P<0.05),而后两者无显著差异(P>0.05).hMSH2在低分化腺癌中的阳性率(80.6% )显著高于高中分化腺癌(57.7%)和黏液癌(53.8%)(P<0.05),而后两者无显著差异(P>0.05).hMLH1在胃炎黏膜组织的阳性表达率(38.2%)显著低于胃癌(77.1%)和癌旁黏膜组织(74.3%)(P<0.05),后两者无显著差异(P>0.05). hMLH1在黏液癌中的阳性率(38.5%)显著低于高中分化腺癌(80.8%)和低分化腺癌(90.3%)(P<0.05),后两者无显著差异(P>0.05).结论 hMSH2高表达可能是胃癌发生的标志之一;hMSH2表达与肿瘤分化程度及患者预后有关;hMLH1有可能作为胃癌预警组织学标记物.

关 键 词:胃癌 hMLH1 hMSH2 免疫组织化学
文章编号:1005-9202(2005)02-0165-03
修稿时间:2004-06-28

Mismatch repair gene hMLH1 and hMSH2 expression in gastric cancer tissue and its significance
FAN Kai,MA Jian-Mei,LIU Min,et al.. Mismatch repair gene hMLH1 and hMSH2 expression in gastric cancer tissue and its significance[J]. Chinese Journal of Gerontology, 2005, 25(2): 165-167
Authors:FAN Kai  MA Jian-Mei  LIU Min  et al.
Affiliation:FAN Kai*,MA Jian-Mei,LIU Min*,et al . Anatomy Department of Dalian Medical University,Dalian 116027,Liaoning,China, *Central Laboratory of the Second Hospital Affiliated to Dalian Medical University,Dalian 116027,Liaoning,China
Abstract:Objective To investigate the role of mismatch repair gene hMLH1 and hMSH2 in carcinogenesis of gastric cancer. Methods The expression of hMLH1 and hMSH2 in sporadic gastric cancer, adjacent mucosa and gastritis mucosa tissue was examined by immunohistochemistry SP method. Results The positive rate of hMSH2 expression in cancer tissue (67.1%) was significantly higher than that in adjacent mucosa (41.4%) and gastritis mucosa tissue (41.2%)(P<0.05); the positive rate in poor differentiated group (80.6%) was significantly higher than those in well differentiated group (57.7%) and mucoid cancer group (53.8%)(P<0.05), but there was no significant difference between the latter two groups (P>0.05). The positive rate of hMLH1 expression (38.2%) was significantly lower than that in gastric cancer (77.1%) and adjacent mucosa tissue (74.3%)(P<0.05); the positive rate in mucoid cancer (38.5%) was significantly lower than those in well (80.8%) and poor differentiated group (90.3%)(P<0.05), but there was no significant difference between the latter two groups (P>0.05). Conclusions The high expression of hMSH2 may be one of potential markers of gastric cancer; the expression of hMSH2 is related to tumor differential degree and prognosis; hMLH1 protein may be a histological marker predicting gastric cancer occurrence.
Keywords:Gastric cancer  hMLH1  hMSH2  Immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号